AC Immune reports positive interim data from ABATE trial of ACI-24
AC Immune (NASDAQ:ACIU) reported 12-month interim data from the Phase 1b/2 ABATE trial of ACI-24 in 74 patients with prodromal Alzheimer’s disease across cohorts AD1-AD3.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
AC Immune (NASDAQ:ACIU) reported 12-month interim data from the Phase 1b/2 ABATE trial of ACI-24 in 74 patients with prodromal Alzheimer’s disease across cohorts AD1-AD3.
Ingredion (NYSE:INGR) completed the sale of a 51% equity interest in its Pakistan business, Rafhan Maize, for approximately $165 million.
XRP (CRYPTO:XRP) traded near US$1.04 after recovering from a 19-month low of about US$1.01, while new wallet creation on the XRP Ledger rose to 4,941 in a single day, its highest level in more than three months.
Britain’s competition regulator proposed allowing app developers to steer users to alternative payment options outside Apple and Google app stores to reduce fees and boost competition.
Nike (NYSE:NKE) reported fourth quarter fiscal 2026 revenue of $11 billion, down 1% on a reported basis and down 4% on a currency-neutral basis.
The US Supreme Court ruled 5-4 that President Donald Trump cannot, for now, remove Federal Reserve Governor Lisa Cook, preserving the central bank's current leadership as Bitcoin (CRYPTO:BTC) traded below US$60,000.
Vena Energy has secured $1.4 billion in debt financing to accelerate its solar and battery storage rollout across Australia.
Imugene (ASX:IMU) announced that the first patient in its azer-cel Phase 1b trial cohort achieved a complete response.
Ondo (CRYPTO:ONDO) was trading at about US$0.3084 as analysts monitored a key technical pattern, with a breakout above resistance potentially targeting US$0.325 and a break below support increasing the risk of short-term selling.
Golden Globe Resources (ASX:GGR) has commenced its Phase 2 diamond drilling programme at the Dooloo Creek Project.